COSMOS Pharmaceutical Corporation CSMYF
39.89 USD 0.00 (+0.00%)
Regular-session close
39.89 Day range 39.89
37.06 52-week range 48.27
- YTD
- -17.36%
- 1 year
- -13.40%
Included in Essentials and up
Sign in to see Fair value
Discounted cash flow estimates against the price, and the P/E against its industry and sector.
Included in Essentials and up
Sign in to see Head count and owner earnings
Employees by annual report and the cash the business earns for its owners.
Included in Essentials and up
Sign in to see P/E against peers
The price to earnings ratio beside the closest competitors and their median.
Included in Essentials and up
Sign in to see Cash flow and returns
How profit turns into free cash flow, and the returns on equity, assets and capital.
Financial health
Altman Z-Score
3.65 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E 14.6×
P/S 0.4×
P/B 1.6×
P/FCF -40.1×
EV/EBITDA 7.2×
EV/Sales 0.4×
FCF Yield -2.5%
Profitability
Gross Margin 20.9%
Operating Margin 3.9%
Net Margin 2.9%
ROE 11.3%
ROIC 8.4%
ROA 5.4%
Growth (YoY)
Revenue 8.8%
Operating Income 4.9%
EPS (diluted) 3.6%
Free Cash Flow -1260.1%
Financial Health
Current Ratio 0.8×
Quick Ratio 0.4×
Debt / Equity 0.3×
Net Debt / EBITDA 0.3×
Interest Coverage 72.9×
Dividends
Dividend Yield 1.3%
Payout Ratio 18.5%
Annual · latest fiscal year ends 2026-05-31
